These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 8567666
1. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide. Gupta KP, Ward NE, Gravitt KR, Bergman PJ, O'Brian CA. J Biol Chem; 1996 Jan 26; 271(4):2102-11. PubMed ID: 8567666 [Abstract] [Full Text] [Related]
2. An N-myristoylated protein kinase C-alpha pseudosubstrate peptide that functions as a multidrug resistance reversal agent in human breast cancer cells is not a P-glycoprotein substrate. Bergman PJ, Gravitt KR, O'Brian CA. Cancer Chemother Pharmacol; 1997 Jan 26; 40(5):453-6. PubMed ID: 9272125 [Abstract] [Full Text] [Related]
3. Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanism. Bergman PJ, Gravitt KR, Ward NE, Beltran P, Gupta KP, O'Brian CA. Invest New Drugs; 1997 Jan 26; 15(4):311-8. PubMed ID: 9547673 [Abstract] [Full Text] [Related]
4. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C. Sachs CW, Safa AR, Harrison SD, Fine RL. J Biol Chem; 1995 Nov 03; 270(44):26639-48. PubMed ID: 7592889 [Abstract] [Full Text] [Related]
5. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. Blobe GC, Sachs CW, Khan WA, Fabbro D, Stabel S, Wetsel WC, Obeid LM, Fine RL, Hannun YA. J Biol Chem; 1993 Jan 05; 268(1):658-64. PubMed ID: 8093247 [Abstract] [Full Text] [Related]
6. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance. Gekeler V, Boer R, Uberall F, Ise W, Schubert C, Utz I, Hofmann J, Sanders KH, Schächtele C, Klemm K, Grunicke H. Br J Cancer; 1996 Sep 05; 74(6):897-905. PubMed ID: 8826855 [Abstract] [Full Text] [Related]
7. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y. Breast Cancer Res; 2001 Sep 05; 3(4):253-63. PubMed ID: 11434876 [Abstract] [Full Text] [Related]
8. Modulation of P-glycoprotein by protein kinase C alpha in a baculovirus expression system. Ahmad S, Safa AR, Glazer RI. Biochemistry; 1994 Aug 30; 33(34):10313-8. PubMed ID: 7915139 [Abstract] [Full Text] [Related]
9. Chemosensitization of cancer cells by the staurosporine derivative CGP 41251 in association with decreased P-glycoprotein phosphorylation. Beltran PJ, Fan D, Fidler IJ, O'Brian CA. Biochem Pharmacol; 1997 Jan 24; 53(2):245-7. PubMed ID: 9037258 [Abstract] [Full Text] [Related]
10. Mechanism of inhibition of P-glycoprotein-mediated drug transport by protein kinase C blockers. Castro AF, Horton JK, Vanoye CG, Altenberg GA. Biochem Pharmacol; 1999 Dec 01; 58(11):1723-33. PubMed ID: 10571246 [Abstract] [Full Text] [Related]
11. Effects of protein kinase C modulators on multidrug resistance in human glioma cells. Matsumoto T, Tani E, Yamaura I, Miyaji K, Kaba K. Neurosurgery; 1995 Mar 01; 36(3):565-71; discussion 572. PubMed ID: 7538636 [Abstract] [Full Text] [Related]
12. Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport. Sharom FJ, Yu X, DiDiodato G, Chu JW. Biochem J; 1996 Dec 01; 320 ( Pt 2)(Pt 2):421-8. PubMed ID: 8973548 [Abstract] [Full Text] [Related]
13. Inhibition of protein kinase C in multidrug-resistant cells by modulators of multidrug resistance. Hu YP, Robert J. J Cancer Res Clin Oncol; 1997 Dec 01; 123(4):201-10. PubMed ID: 9177492 [Abstract] [Full Text] [Related]
14. Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha. Cloud-Heflin BA, McMasters RA, Osborn MT, Chambers TC. Eur J Biochem; 1996 Aug 01; 239(3):796-804. PubMed ID: 8774728 [Abstract] [Full Text] [Related]
15. Differential modulation of P-glycoprotein transport by protein kinase inhibition. Bates SE, Lee JS, Dickstein B, Spolyar M, Fojo AT. Biochemistry; 1993 Sep 07; 32(35):9156-64. PubMed ID: 7690250 [Abstract] [Full Text] [Related]
16. Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance. Posada JA, McKeegan EM, Worthington KF, Morin MJ, Jaken S, Tritton TR. Cancer Commun; 1989 Sep 07; 1(5):285-92. PubMed ID: 2577153 [Abstract] [Full Text] [Related]
17. Melphalan resistance and photoaffinity labelling of P-glycoprotein in multidrug-resistant Chinese hamster ovary cells: reversal of resistance by cyclosporin A and hyperthermia. Larrivée B, Averill DA. Biochem Pharmacol; 1999 Jul 15; 58(2):291-302. PubMed ID: 10423171 [Abstract] [Full Text] [Related]
18. A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. Eichholtz T, de Bont DB, de Widt J, Liskamp RM, Ploegh HL. J Biol Chem; 1993 Jan 25; 268(3):1982-6. PubMed ID: 8420972 [Abstract] [Full Text] [Related]
19. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine. Ferry D, Boer R, Callaghan R, Ulrich WR. Int J Clin Pharmacol Ther; 2000 Mar 25; 38(3):130-40. PubMed ID: 10739116 [Abstract] [Full Text] [Related]
20. Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores. Sharom FJ, DiDiodato G, Yu X, Ashbourne KJ. J Biol Chem; 1995 Apr 28; 270(17):10334-41. PubMed ID: 7730340 [Abstract] [Full Text] [Related] Page: [Next] [New Search]